Zimmer Biomet Holdings Restructuring And Other Cost Reduction Initiatives decreased by 94.1% to $6.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 82.5%, from $36.00M to $6.30M. Over 4 years (FY 2021 to FY 2025), Restructuring And Other Cost Reduction Initiatives shows an upward trend with a 9.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High costs indicate active transformation, which may lead to future margin expansion but creates short-term earnings volatility.
Restructuring and cost reduction initiative expenses represent one-time or non-recurring costs associated with reorganiz...
Varies by company lifecycle and strategic shifts; peers undergoing integration or consolidation will show higher levels.
other_restructuring_and_other_cost_reduction_initiatives| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.80M | $22.50M | $63.10M | $43.90M | $57.00M | $28.30M | $62.40M | $41.80M | $24.40M | $24.30M | $61.30M | $124.40M | $41.50M | $32.20M | $20.90M | $36.00M | $17.50M | $21.40M | $106.30M | $6.30M |
| QoQ Change | — | +19.7% | +180.4% | -30.4% | +29.8% | -50.4% | +120.5% | -33.0% | -41.6% | -0.4% | +152.3% | +102.9% | -66.6% | -22.4% | -35.1% | +72.2% | -51.4% | +22.3% | +396.7% | -94.1% |
| YoY Change | — | — | — | — | +203.2% | +25.8% | -1.1% | -4.8% | -57.2% | -14.1% | -1.8% | +197.6% | +70.1% | +32.5% | -65.9% | -71.1% | -57.8% | -33.5% | +408.6% | -82.5% |